Latest scientific news
The research will explore key challenges in cancer, from metastasis and treatment resistance to childhood tumours and the effects of cancer on the body.
The new laboratory will join IRB Barcelona's Aging and Metabolism research programme, expanding the Institute's capabilities in therapeutic discovery.
The team will receive €90,000 to investigate why malignant rhabdoid tumours can resist treatment.
The European grant, worth €2.5M, will allow the recruitment of research personnel and the deployment of advanced tumour analysis technologies.
The project brings together 25 partners across 8 countries and incorporates Almirall, Sanofi, and other pharmaceutical companies to provide feedback and evaluate the practical usefulness of the platform in industrial settings.
